net sodium reabsorption by the kidney. Because several lines of evidence have suggested a direct role of the sympathetic nervous system in renal sodium homeostasis 1 4, 5 7 , 10-17 it has been implicated as well in the renal vascular response to salt restriction."' 4 7, 15 In this study, this possibility has been examined directly in normal man by assessing the renal vascular effects of adrenergic blockade induced with phentolamine infused into the renal artery in subjects on a restricted salt intake. Because it was possible in this way to achieve renal concentrations of phentolamine in excess of 30 times the threshold for blockade, the absence of a significant increase in renal blood flow suggests strongly that the sympathetic nervous system is not involved in the renal vascular response to salt restriction.
Methods
The subjects were Studies were carried out in 33 subjects. In 12 subjects, replicate serial determinations of renal blood flow were carried out without the infusion of vasoactive drugs. In another 10 subjects, phentolamine was infused intra-arterially after a control blood flow study; in six of the 10, at two or more log-dose levels. In the other four, phentolamine was infused at a single dose level from 0.1 to 3.0 mg/min, and a 6-pg bolus of epinephrine was injected to assess the degree of alphaadrenergic blockade. The effect of the same dose of epinephrine on intrarenal hemodynamics in the absence of phentolamine was assessed in six subjects, as reported previously. '8 The ability of the xenon washout method to detect an increase in renal blood flow was assessed in another five subjects, with the intraarterial infusion of acetylcholine at 10 ,ug/min.
The drugs utilized were phentolamine mesylate (Regitine; Ciba), acetylcholine chloride (Merck), and epinephrine hydrochloride (Adrenalin chloride; Parke-Davis). All doses have been calculated as the salt of the solution.
The methods used for assessing intrarenal hemodynamics with the xenon washout method in man are modified slightly from those used in the dog,4 5, 7.19 as described in detail elsewhere. 1' 20 In brief, 133Xe in saline solution was injected into the renal artery through the outer catheter, -and its disappearance from the kidney was monitored by external counting. Mean renal blood flow was calculated from the initial slope. To make serial blood flow studies possible a modified compartmental analysis was carried out on the data; the two slowest components were approximated by a single value.'9' 20 For xenon, the optimal constant has been found to be the count rate 3 min after the peak. Flow rate in the most rapid flow component was calculated from the rate constant and the percentage of flow entering this compartment from the zero-time intercept. The serial studies were carried out at intervals of 5 to 15 min, when the count rate had generally fallen to less than 5% of the peak count.1' 20 Repeat selective arteriograms were also carried out during the infusion of the vasodilator drug at the end of the third blood flow determination.
Written permission was obtained for the study from each subject after a detailed description of the procedures. The protocols have been approved by the Human Experimentation Committee of the Peter Bent Brigham Hospital.
Mean values are followed by the standard error of the mean as the index of dispersion. Tests of statistical significance between means reported in this study were calculated either by the Student t-test, or by paired data analysis where appropriate. The significance of individual changes was also assessed by comparison with the 95% confidence interval in the relevant control population.
Results
Mean renal blood flow in this group of saltrestricted subjects was 274 ± 4 ( sEm ) ml/100 g/min prior to infusion of vasoactive agents, significantly less than our normal value of 338 + 7 ml/100 g/min for renal blood flow in subjects on an unrestricted salt intake (P<0.01). Phentolamine infused into the renal artery in doses ranging from 0.1 mg/min to 3.0 mg/min failed to alter renal blood flow ( fig.  1 ) in all but one subject. In figure 1 the shaded area represents the 95% confidence limits about flow replication in the serial determinations in normal salt-restricted subjects. The only subject to show an increase in flow which fell outside our confidence interval for replication was the patient with essential hypertension, in whom a significant flow increase occurred with the infusion of both 1.0 and 3.0 mg/min.
Epinephrine injected into the renal artery reduced mean renal blood flow to from 29 to 46% of control levels in six subjects ( fig. 2 ). Epinephrine-induced vasoconstriction was unrecognizable in the subjects receiving phentolamine at doses of 0.3 to 3.0 mg/min. In the subject receiving phentolamine at 0.1 mg/min, renal blood flow fell by 92 ml/ 100 g/min after epinephrine, a reduction outside both the confidence interval for flow replication and for the effect of epinephrine. This dose, therefore, represents the threshold for the blocking action of phentolamine in this system, when a large dose of epinephrine is used. Because phentolamine is a competitive blocking agent, it seems likely that a lower threshold would have been demonstrated if a smaller test dose of epinephrine had been used.
The acetylcholine infusion resulted in a significant increase in renal perfusion in all five subjects, ranging from 170 to 320 ml/100 g/min ( fig. 1) The pattern of perfusion in the kidney associated with the blood flow reduction induced by salt restriction is strikingly similar to that resulting from mild sympathetic activation in both the experimental animal7 and man.6 This similarity and the welldocumented effects of sympathetic activity on renal sodium handling have resulted in the attractive hypothesis that such activity plays a role in normal renal sodium handling.17 The effects of guanethidine, an agent which prevents neural release of catecholamines, on sodium homeostasis in man are consistent with this hypothesis.15 Treatment with guanethidine resulted in a significant impairment of normal subjects' ability to retain sodium in response to a low salt diet. The systemic administration of such an agent, however, inevitably must result in significant effects on all structures innervated by sympathetic nerves so that its effects on sodium homeostasis cannot be attributed with assurance to a primary action on the nerves to the kidney. '7 The results of the present study do not support hypotheses which suggest that the sympathetics mediate the reduction in renal perfusion induced by salt restriction. Before a negative pharmacologic study can be interpreted, two criteria must be met: (1) These observations support the earlier suggestion that in normal supine man there is minimal sympathetic activity to the kidney,'6 and extends it to include normal man in whom moderate plasma volume depletion has been induced by salt restriction. The approach utilized should be useful in delineating the role of the sympathetic nerves to the kidney in a number of processes. The chance observation that phentolamine induced a significant increase in renal perfusion in a patient with essential hypertension requires further investigation, especially in view of the hypertension induced in the experimental animal by chronic splanchnic stimulation.27 While most of the available evidence suggests that a diffuse increase in sympathetic activity does not occur in patients with essential hypertension, regionally differentiated autonomic activity is well documented in animal models28-30 and must be assessed in this setting.
The mechanism by which sodium restriction induces renal vasoconstriction remains unclear. The well-documented relationship between salt balance and renin secretion suggests the possibility that a local increase in angiotensin concentration contributes to the vasoconstriction.8' Recent studies have shown, however, that angiotensin octapeptide is unlikely to be a specific intrarenal hormone because the rate-limiting step in the reninangiotensin sequence is a converting enzyme which is primarily found in lung. 32 The possibility that other, as yet undefined, mediators are involved in the renal vascular response to salt restriction requires further investigation. The definition of the mechanism accounting for the reduction in renal perfusion and its redistribution within the normal kidney should provide insights into both the mechanism of salt retention in states characterized by edema and certain abnormalities of sodium homeostasis in patients with essential hypertension.33
